{"id":41863,"date":"2025-09-19T15:00:42","date_gmt":"2025-09-19T07:00:42","guid":{"rendered":"https:\/\/flcube.com\/?p=41863"},"modified":"2025-09-19T15:00:43","modified_gmt":"2025-09-19T07:00:43","slug":"ge-healthcare-eyes-sale-of-china-unit-amid-revenue-decline","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=41863","title":{"rendered":"GE Healthcare Eyes Sale of China Unit Amid Revenue Decline"},"content":{"rendered":"\n<p><strong>GE Healthcare Technologies Inc.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/GEHC:NASDAQ\">NASDAQ: GEHC<\/a>) is reportedly exploring the sale of a stake in its China operations, according to media reports. The U.S.\u2011based medical\u2011technology firm is working with advisers to assess potential transactions that could value its China assets at \u201cseveral billion dollars,\u201d sources said. No definitive timeline or deal size has been announced, and the company emphasized that preliminary considerations are still under review.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-business-context\">Business Context<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>2024 Revenue<\/strong>: GE Healthcare generated <strong>USD\u202f2.4\u202fbillion<\/strong> from China, a <strong>15\u202f% decline<\/strong> compared with 2023.<\/li>\n\n\n\n<li><strong>Q2 Performance<\/strong>: Revenue from the Chinese market fell another <strong>3\u202f%<\/strong> in the three months ended June.<\/li>\n\n\n\n<li><strong>Market Headwinds<\/strong>: The company cited an anti\u2011corruption crackdown in the Chinese health\u2011care sector as a key driver of delayed orders and reduced sales.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-implications\">Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Portfolio Realignment<\/strong>: The potential divestiture could allow GE to refocus on core high\u2011margin assets while monetising a segment that has underperformed in recent years.<\/li>\n\n\n\n<li><strong>Capital Allocation<\/strong>: Proceeds from a sale could fund R&amp;D, expand digital\u2011health ventures, or strengthen the company\u2019s balance sheet amid a challenging macro environment.<\/li>\n\n\n\n<li><strong>Competitive Landscape<\/strong>: A sale could open the door for local competitors or international buyers looking to consolidate their presence in China\u2019s medical\u2011technology market.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-next-steps\">Next Steps<\/h2>\n\n\n\n<p>GE Healthcare\u2019s advisers are conducting a thorough valuation, exploring both strategic and financial buyers. The company has yet to disclose any finalized offers or a definitive exit strategy. Stakeholders will likely monitor the situation closely, as any significant transaction could reshape the competitive dynamics in China\u2019s medical\u2011technology sector.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>GE Healthcare Technologies Inc. (NASDAQ: GEHC) is reportedly exploring the sale of a stake in&#8230;<\/p>\n","protected":false},"author":1,"featured_media":41865,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[1],"tags":[431,1209],"class_list":["post-41863","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-ge-healthcare","tag-nasdaq-gehc"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>GE Healthcare Eyes Sale of China Unit Amid Revenue Decline - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"GE Healthcare Technologies Inc. (NASDAQ: GEHC) is reportedly exploring the sale of a stake in its China operations, according to media reports. The U.S.\u2011based medical\u2011technology firm is working with advisers to assess potential transactions that could value its China assets at \u201cseveral billion dollars,\u201d sources said. No definitive timeline or deal size has been announced, and the company emphasized that preliminary considerations are still under review.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=41863\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GE Healthcare Eyes Sale of China Unit Amid Revenue Decline\" \/>\n<meta property=\"og:description\" content=\"GE Healthcare Technologies Inc. (NASDAQ: GEHC) is reportedly exploring the sale of a stake in its China operations, according to media reports. The U.S.\u2011based medical\u2011technology firm is working with advisers to assess potential transactions that could value its China assets at \u201cseveral billion dollars,\u201d sources said. No definitive timeline or deal size has been announced, and the company emphasized that preliminary considerations are still under review.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=41863\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-19T07:00:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-19T07:00:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1902.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41863#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41863\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"GE Healthcare Eyes Sale of China Unit Amid Revenue Decline\",\"datePublished\":\"2025-09-19T07:00:42+00:00\",\"dateModified\":\"2025-09-19T07:00:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41863\"},\"wordCount\":269,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41863#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1902.webp\",\"keywords\":[\"GE Healthcare\",\"NASDAQ: GEHC\"],\"articleSection\":[\"Others\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41863#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41863\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=41863\",\"name\":\"GE Healthcare Eyes Sale of China Unit Amid Revenue Decline - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41863#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41863#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1902.webp\",\"datePublished\":\"2025-09-19T07:00:42+00:00\",\"dateModified\":\"2025-09-19T07:00:43+00:00\",\"description\":\"GE Healthcare Technologies Inc. (NASDAQ: GEHC) is reportedly exploring the sale of a stake in its China operations, according to media reports. The U.S.\u2011based medical\u2011technology firm is working with advisers to assess potential transactions that could value its China assets at \u201cseveral billion dollars,\u201d sources said. No definitive timeline or deal size has been announced, and the company emphasized that preliminary considerations are still under review.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41863#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=41863\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41863#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1902.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/1902.webp\",\"width\":1080,\"height\":608,\"caption\":\"GE Healthcare Eyes Sale of China Unit Amid Revenue Decline\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=41863#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GE Healthcare Eyes Sale of China Unit Amid Revenue Decline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"GE Healthcare Eyes Sale of China Unit Amid Revenue Decline - Insight, China&#039;s Pharmaceutical Industry","description":"GE Healthcare Technologies Inc. (NASDAQ: GEHC) is reportedly exploring the sale of a stake in its China operations, according to media reports. The U.S.\u2011based medical\u2011technology firm is working with advisers to assess potential transactions that could value its China assets at \u201cseveral billion dollars,\u201d sources said. No definitive timeline or deal size has been announced, and the company emphasized that preliminary considerations are still under review.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=41863","og_locale":"en_US","og_type":"article","og_title":"GE Healthcare Eyes Sale of China Unit Amid Revenue Decline","og_description":"GE Healthcare Technologies Inc. (NASDAQ: GEHC) is reportedly exploring the sale of a stake in its China operations, according to media reports. The U.S.\u2011based medical\u2011technology firm is working with advisers to assess potential transactions that could value its China assets at \u201cseveral billion dollars,\u201d sources said. No definitive timeline or deal size has been announced, and the company emphasized that preliminary considerations are still under review.","og_url":"https:\/\/flcube.com\/?p=41863","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-19T07:00:42+00:00","article_modified_time":"2025-09-19T07:00:43+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1902.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=41863#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=41863"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"GE Healthcare Eyes Sale of China Unit Amid Revenue Decline","datePublished":"2025-09-19T07:00:42+00:00","dateModified":"2025-09-19T07:00:43+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=41863"},"wordCount":269,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=41863#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1902.webp","keywords":["GE Healthcare","NASDAQ: GEHC"],"articleSection":["Others"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=41863#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=41863","url":"https:\/\/flcube.com\/?p=41863","name":"GE Healthcare Eyes Sale of China Unit Amid Revenue Decline - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=41863#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=41863#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1902.webp","datePublished":"2025-09-19T07:00:42+00:00","dateModified":"2025-09-19T07:00:43+00:00","description":"GE Healthcare Technologies Inc. (NASDAQ: GEHC) is reportedly exploring the sale of a stake in its China operations, according to media reports. The U.S.\u2011based medical\u2011technology firm is working with advisers to assess potential transactions that could value its China assets at \u201cseveral billion dollars,\u201d sources said. No definitive timeline or deal size has been announced, and the company emphasized that preliminary considerations are still under review.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=41863#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=41863"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=41863#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1902.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1902.webp","width":1080,"height":608,"caption":"GE Healthcare Eyes Sale of China Unit Amid Revenue Decline"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=41863#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"GE Healthcare Eyes Sale of China Unit Amid Revenue Decline"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/1902.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41863"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41863\/revisions"}],"predecessor-version":[{"id":41866,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/41863\/revisions\/41866"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/41865"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}